Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 10/20 | 0.48 |
| ▸ | NPY1R | P25929 | 7/20 | 0.48 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
| ▸ | NPY2R | P49146 | 6/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.39 |
| ▸ | NMT2 | O60551 | 1/20 | 0.38 |
| ▸ | NMT1 | P30419 | 1/20 | 0.38 |
| ▸ | ERAP2 | Q6P179 | 4/20 | 0.37 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.37 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.36 |
| ▸ | TLR2 | O60603 | 1/20 | 0.36 |
| ▸ | FURIN | P09958 | 1/20 | 0.36 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.36 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.36 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16263594 | 0.94 | NPY4R (0.49) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL20620363 | 0.88 | NPY4R (0.48) | NPY4RNPY1RSIRT6SIRT1NPY2R | |
| SCHEMBL10792547 | 0.88 | NPY4R (0.57) | NPY4RNPY1RSIRT6SIRT1NPY2R | |
| SCHEMBL21782583 | 0.88 | NPY4R (0.46) | NPY4RNPY1RSIRT6SIRT1NPY2R | |
| SCHEMBL10792564 | 0.88 | NPY4R (0.57) | NPY4RNPY1RSIRT6SIRT1NPY2R | |
| SCHEMBL18671824 | 0.88 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RNMT2 | |
| SCHEMBL18671700 | 0.88 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RNMT2 | |
| SCHEMBL16263606 | 0.87 | ERAP2 (0.43) | SIRT6SIRT1NMT2NMT1ERAP2 | |
| SCHEMBL16263608 | 0.84 | MEN1 (0.44) | NPY4RNPY1R | |
| SCHEMBL23048407 | 0.84 | NPY4R (0.43) | NPY4RNPY1RNPY2RNPY5RLNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2753613-B1 | DERIVATIVES OF XANTHONE COMPOUNDS | AGENCY SCIENCE TECH & RES (SG) | 2020-03-04 | — | — | EP | disclosed |
| US-20140349918-A1 | DERIVATIVES OF XANTHONE COMPOUNDS | SINGAPORE HEALTH SERVICES PTE LTD. (SG) | 2014-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140349918-A1 | DERIVATIVES OF XANTHONE COMPOUNDS | XDH, XPA, SQLE | NPY4R 1057/4885NPY1R 927/4885SIRT6 1326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.